23.75
price down icon3.28%   -0.805
 
loading

Beam Therapeutics Inc Azioni (BEAM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
98.46%
0.49
31.74 114.11 9.698 8.466
Operating Expenses
8.57%
127.04
138.95 131.55 136.51 128.62
Depreciation and Amortization
3.48%
5.41
5.605 5.668 5.56 5.538
Operating Income/Loss
18.04%
-126.55
-107.22 -17.45 -126.81 -120.15
Nonoperating Income/Loss
69.95%
3.875
12.90 261.74 14.08 17.86
Income Tax Expense/Benefit
-
- - - -
Net Income/Loss
30.07%
-122.68
-94.32 244.30 -112.73 -102.29
Basic Average Shares
1.03%
104.33
103.26 1.3383 102.57 102.00
Diluted Average Shares
1.03%
104.33
103.26 1.3383 102.57 102.00
Basic Earnings Per Share
29.67%
-1.18
-0.91 2.51 -1.10 -1.00
Diluted Earnings Per Share
29.67%
-1.18
-0.91 2.51 -1.10 -1.00
$10.74
price down icon 1.92%
$18.84
price down icon 2.69%
$19.88
price down icon 7.88%
$22.45
price down icon 1.64%
MBX MBX
$47.85
price down icon 5.17%
SLS SLS
$11.37
price up icon 0.13%
Capitalizzazione:     |  Volume (24 ore):